back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-12 11:21 Tx date 2026-06-03 |
$DTC
Defence Therapeutics Inc. |
Beaver, John David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+150,000 vol $0.60 each |
150,000 | |
| Filed 2026-06-12 11:11 Tx date 2026-06-03 |
$DTC
Defence Therapeutics Inc. |
Beaver, John David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-09 21:20 Tx date 2026-06-01 |
$DTC
Defence Therapeutics Inc. |
Lambert, John Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2026-05-03 22:13 Tx date 2026-04-30 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+200,000 vol |
1,800,000 | |
| Filed 2026-05-03 22:08 Tx date 2026-04-30 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted share units
57 - Exercise of rights
|
-200,000 vol |
0 | |
| Filed 2026-04-28 15:39 Tx date 2026-04-24 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted share units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2026-04-28 15:37 Tx date 2021-05-03 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted share units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-27 13:54 Tx date 2026-03-06 |
$DTC
Defence Therapeutics Inc. |
Rifai, Omar
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+5,000,000 vol |
5,750,000 | |
| Filed 2026-03-27 13:54 Tx date 2026-03-06 |
$DTC
Defence Therapeutics Inc. |
Rifai, Omar
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2026-03-27 13:53 Tx date 2026-03-06 |
$DTC
Defence Therapeutics Inc. |
Rifai, Omar
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$2,750,000
+5,000,000 vol $0.55 each |
5,750,000 | |
| Filed 2026-03-27 13:53 Tx date 2026-03-06 |
$DTC
Defence Therapeutics Inc. |
Rifai, Omar
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2025-12-16 12:43 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Selivanova, Svetlana
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
| Filed 2025-12-16 10:29 Tx date 2025-09-16 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-16 10:28 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 | |
| Filed 2025-12-16 10:26 Tx date 2025-09-16 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-09-22 10:05 Tx date 2025-09-16 |
$DTC
Defence Therapeutics Inc. |
Lambermon-Phinney, Amie Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-15 15:28 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,400,000 | |
| Filed 2025-12-10 17:21 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
||
| Filed 2025-12-11 16:42 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-11 16:39 Tx date 2025-12-10 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Holder: Gestion Philippe Lefrancois Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
+50,000 vol |
150,000 |